Cue Health
Building a business on pandemic demand without a diversification plan is existential risk.
Cue Health was a Healthcare/Diagnostics startup founded in 2010 in USA. It raised $600M+ before collapsing in 2023 — 13 years of runway burned. IdeaProof's AI Failure Score: 65/100, driven by post-pandemic demand collapse. The shutdown affected employees, investors, and the broader Healthcare/Diagnostics ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.
Why did Cue Health fail?
Cue Health failed in 2023 after 13 years of operation, losing $600M+ in raised capital. The root cause was post-pandemic demand collapse. Key lesson: Building a business on pandemic demand without a diversification plan is existential risk.
2010 → 2023
$600M+
Healthcare/Diagnostics
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2010
Cue Health founded to build molecular diagnostics
2021
Revenue reaches $481M from COVID testing
2022
COVID testing demand drops sharply
2023
Files for bankruptcy as revenue collapses
Root Causes
Cue Health built a molecular diagnostic testing device for COVID-19 that offered lab-quality results at home. Revenue exploded to $481M in 2021 during the pandemic. But when COVID testing demand evaporated in 2022-2023, Cue's revenue collapsed and the company couldn't pivot its technology to other diagnostics fast enough. Cue filed for bankruptcy in 2023, unable to sustain operations on declining revenue.
Sources & References
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Cue Health.